Best Doctors for Breast Cancer Treatment in India

Breast cancer is treated by a team rather than by one doctor, and the depth of that team is the practical reason most international patients come.

1. The Plan Should Come From a Tumour Board

Breast cancer treatment involves decisions about sequence as much as about technique: whether surgery comes first, whether systemic treatment beforehand would allow a smaller operation, and what follows. Those decisions belong to a meeting, not to one person.

At the large Indian cancer centres these specialists review cases together before anyone operates:

• Breast surgeon

• Medical oncologist

• Radiation oncologist

• Radiologist

• Pathologist

Ask whether your case will go to that meeting, and ask for the recorded conclusion in writing.

2. Pathology and Biomarker Testing on Site

The treatment plan rests on what the pathology shows, including hormone receptor and HER2 testing. Where those results are equivocal or a second opinion is wanted, having the laboratory in the same institution shortens the wait considerably.

Ask whether your existing slides and blocks can be reviewed here, because repeat testing on arrival is common and worth planning for.

3. Reconstruction Available in the Same Sitting

Where mastectomy is recommended, whether reconstruction happens at the same operation or as a separate procedure later changes the total time, the cost and the result. The large centres offer both routes.

Settle this before surgery rather than afterwards. Finding out later that the option you wanted needed a different plan from the start is a poor way to learn it.

4. Consultations in English

Clinical work at the major centres runs in English, so you can read your own pathology report and carry home a discharge summary your own oncologist can act on. Interpreters for Arabic, French, Russian and Kiswahili are available at most of the hospitals in this directory, arranged before you arrive.

5. Cost, and Why the Range Is Wide

Costs in India are generally lower than in Europe, North America or the Gulf. But breast cancer is not one treatment with one price, and published figures for the systemic part vary by more than tenfold depending on what is prescribed.

Section 12 sets out the published figures and explains the spread. Any total quoted before your pathology has been read is guesswork.

1. Raise Fertility Before Treatment Starts

This comes first because the window closes, not because it matters more than the cancer.

Several breast cancer treatments can affect fertility, some permanently. Systemic treatment given before or after surgery is the main concern, and hormone treatment taken for years afterwards delays pregnancy by its own duration.

If there is any chance you would want children later, say so at your first consultation and ask for a referral to a fertility specialist before treatment begins. Egg or embryo freezing takes time to arrange and generally has to happen before systemic treatment starts.

This applies whatever your age, and it applies even where treatment is urgent. Raising it costs you nothing. Raising it late can cost you the option entirely.

2. What Breast Cancer Treatment Is

Breast cancer treatment aims to remove or control the cancer, reduce the chance of it coming back, and where the disease is advanced, to control it and maintain quality of life for as long as possible.

Treatments fall into two broad groups:

• Local treatments act on the breast and the nearby lymph nodes: surgery and radiation therapy

• Systemic treatments act throughout the body: chemotherapy, hormone therapy, targeted therapy and immunotherapy

Most patients receive some combination rather than one alone. Which combination, and in what order, is what the treatment plan decides. That plan is built from the pathology, the stage and your own circumstances rather than from a standard protocol.

For the treatment pathway across breast cancer generally, see breast cancer treatment in India.

3. How the Treatment Plan Is Decided

This is the section worth reading twice, because it explains why two people with the same diagnosis receive different treatment.

The plan is built from these together:

• Stage, meaning how far the cancer has spread

• Tumour size

• Lymph node involvement, established by examining nodes removed at surgery or sampled beforehand

• Oestrogen receptor status, a test on the tumour tissue

• Progesterone receptor status, tested alongside it

• HER2 status, a further test on the same tissue

• Tumour grade, meaning how abnormal the cells appear

• Menopausal status, which affects which hormone treatments are appropriate

• Genetic and biomarker findings, where testing has been done

• Your overall health, other conditions, and what you want from treatment

The three receptor tests matter more than most patients are told. Together they define the biological type of the cancer, and that type determines which systemic treatments can work at all. A cancer that does not carry hormone receptors will not respond to hormone treatment, whatever its stage.

Ask for your pathology report and ask someone to walk you through these results. They are the foundation of everything that follows.

4. The Main Treatment Options

Surgery

Surgery removes the tumour and establishes what is in the lymph nodes. The main choices:

• Breast-conserving surgery, sometimes called lumpectomy, removes the tumour with a margin of surrounding tissue and keeps the breast

• Mastectomy removes all the breast tissue, and is recommended where the tumour is large relative to the breast, where there is more than one tumour, or by patient choice

• Sentinel lymph node biopsy samples the first nodes the breast drains to, avoiding removal of all the armpit nodes where those first nodes are clear

• Axillary dissection removes more nodes, and is used where disease is known to have reached them

• Reconstruction rebuilds the breast, either at the same operation or later, using an implant or the patient's own tissue

Breast-conserving surgery followed by radiation is generally comparable to mastectomy for suitable patients. That is a conversation worth having rather than assuming the larger operation is the safer one.

Chemotherapy

• What it is: systemic medicines that destroy cancer cells throughout the body

• How it is given: in cycles, usually over several months

• When it is used: before surgery to shrink a tumour, after surgery to reduce recurrence risk, or as the main treatment in advanced disease

• What decides it: the biological type as much as the stage, not the stage alone

Radiation Therapy

• What it is: targeted high-energy treatment to the breast, chest wall or nearby lymph node areas

• How it is given: daily sessions over a period of weeks

• When it is used: standard after breast-conserving surgery, and after mastectomy in defined situations

Hormone Therapy

• What it is: treatment that blocks or lowers the hormones a cancer uses to grow

• Who it applies to: cancers carrying hormone receptors

• How long: usually several years after other treatment finishes, which is longer than most patients expect and worth planning for

Targeted Therapy

• What it is: treatment directed at a specific feature of the cancer cell

• Who it applies to: most commonly where HER2 testing is positive

• How it is given: alongside other treatment rather than instead of it

Immunotherapy

• What it is: treatment that works through the immune system

• When it is used: in defined situations, usually in combination

• What it is not: appropriate for every breast cancer, or a general alternative to other treatment

5. Treatment Before and After Surgery

The order matters as much as the choice, and this distinction is worth understanding before you consent to anything.

Neoadjuvant treatment is given before surgery. It can:

• Shrink a large tumour enough to allow breast-conserving surgery instead of mastectomy

• Make an inoperable tumour operable

• Show the team how the cancer responds to treatment, which is information they cannot get any other way

Adjuvant treatment is given after surgery, to reduce the risk of the cancer returning. It:

• May include chemotherapy, radiation, hormone treatment, targeted treatment, or a combination

• Is guided by what the pathology showed once the tumour was removed

If surgery has been proposed as the first step, it is reasonable to ask whether systemic treatment beforehand was considered and why it was not chosen. For some cancer types that sequence is standard rather than exceptional.

6. Treatment by Stage

Stage describes how far the cancer has spread. It shapes treatment but does not determine it on its own, because two cancers at the same stage with different biology are treated differently.

• Stage 0. Abnormal cells confined to the ducts, sometimes called in situ disease. Usually surgery, often with radiation, and hormone treatment where receptors are present.

• Stage I. A small tumour with no or minimal node involvement. Usually surgery, with radiation after breast-conserving surgery, and systemic treatment guided by the biology.

• Stage II. A larger tumour or limited node involvement. Surgery and systemic treatment are both usual, and the order between them is a real decision rather than a formality.

• Stage III. Locally advanced disease, involving more nodes or the chest wall or skin. Systemic treatment before surgery is common, followed by surgery and radiation.

• Stage IV. Also called metastatic breast cancer, meaning the disease has spread beyond the breast and nearby nodes. Systemic treatment is central, directed at controlling the disease and maintaining quality of life rather than at removing it. Surgery and radiation still have roles for specific problems.

Being told your cancer is stage IV is not the end of treatment options. Many people live with metastatic breast cancer for years on treatment that is adjusted over time.

7. Treatment by Type

The biological type often matters more than the stage in deciding which treatments can work.

• Hormone receptor-positive. Carries oestrogen or progesterone receptors, or both, and is the commonest type. Hormone treatment is central, usually for several years, and chemotherapy is not always required even where the tumour is not tiny.

• HER2-positive. Shows a positive result on HER2 testing. Targeted treatment directed at that feature is central and is given alongside chemotherapy in most situations. This type was historically difficult to treat, and the outlook changed substantially once targeted treatment became available.

• Triple-negative. Carries neither hormone receptor and tests negative for HER2, so hormone and HER2-targeted treatments do not apply. Chemotherapy carries more of the load, with immunotherapy used in defined situations. It tends to occur in younger women and is more common in some populations than others.

• Inflammatory breast cancer. Uncommon and behaves differently. The breast becomes red, swollen and warm, often without a distinct lump, and it is frequently mistaken for infection at first. Treated as locally advanced disease with systemic treatment first, and it needs prompt specialist assessment rather than a trial of antibiotics.

• Metastatic breast cancer. Treated according to its biological type as much as its spread. The type is sometimes retested on a metastatic site, because it can differ from the original tumour.

8. Who Is on the Team, and Why You Need More Than One Specialist

This page sits in the surgical oncology directory, but breast cancer treatment is not a surgical problem alone. Most patients see several specialists, and the sequence is usually something like this.

• Radiologist. Reads the imaging and often performs the biopsy that establishes the diagnosis.

• Pathologist. Examines the tissue and reports the type, grade and receptor status. Everything downstream depends on this report.

• Breast surgeon or surgical oncologist. Performs the operation and decides how the lymph nodes are handled. Compare specialists in our surgical oncology directory for India.

• Medical oncologist. Directs chemotherapy, hormone treatment, targeted treatment and immunotherapy. For many patients this is the doctor they see most over the following years. See medical oncologists across India.

• Radiation oncologist. Plans and delivers radiation therapy. See radiation oncologists in India.

• Plastic or reconstructive surgeon. Involved where reconstruction is part of the plan, working alongside the breast surgeon.

If you are choosing a hospital rather than a single doctor, this is why. A centre where these specialists work together and meet regularly is a different proposition from one where you assemble the team yourself.

9. Records to Bring or Send

An opinion given without these is provisional. Send:

• The biopsy or pathology report in full, including receptor and HER2 results

• Where possible, the slides and paraffin blocks themselves, since repeat testing on arrival is common

• Mammogram, ultrasound and MRI reports, with the image files rather than only the written reports

• Any staging scans already performed

• Recent blood test results

• A list of your current medicines

• Records of any treatment already given, including how many cycles and when

• Details of other medical conditions

The pathology report is the single most important document. A specialist can give a far more useful opinion with it than without it, and sending it costs you nothing.

10. What Determines the Best Treatment for You

There is no single breast cancer treatment that is best for everyone, and any source suggesting otherwise is not describing this disease.

The plan is built after reviewing the pathology, the receptor and HER2 results, the stage, the imaging, your general health and what you want from treatment. A multidisciplinary team then recommends surgery, systemic therapy, radiation, or some combination, in an order chosen for your situation.

Two people with the same stage can receive entirely different treatment because their tumour biology differs. That is not inconsistency. It is the point.

What you can reasonably expect is that someone explains why this plan and not another, and that the reasoning refers to your own results rather than to general practice.

11. Questions to Ask Before You Consent

Written answers are more useful than verbal ones, particularly if you are travelling.

• What are my receptor and HER2 results, and what do they mean for my treatment?

• What stage is my cancer, and what was that based on?

• Will my case go to a multidisciplinary meeting, and can I have the conclusion in writing?

• Do you recommend surgery first, or treatment before surgery, and why?

• Am I a candidate for breast-conserving surgery rather than mastectomy?

• How will the lymph nodes be handled?

• If mastectomy is recommended, what are my reconstruction options and when would it happen?

• Could this treatment affect my fertility, and should I see a fertility specialist first?

• How long will systemic treatment last, and how much of it can be given at home?

• What is the total expected timeline from now to the end of active treatment?

• What follow-up will I need, and can it be done in my own country?

• What happens, and who pays, if a complication develops while I am still in India?

12. Published Costs, and Why the Range Is So Wide

The figures below are published indicative ranges, checked in August 2026. They are not quotes, and breast cancer is a treatment course rather than a single procedure, so no one figure covers it.

• Surgery, overall: roughly 1,000 to 7,000 dollars depending on the operation

• Lumpectomy: quoted from about 1,600 upward, commonly 2,000 to 4,000

• Mastectomy: roughly 3,000 to 7,000, with several sources clustering at 4,000 to 6,000

• Reconstruction: quoted separately at around 3,000 to 4,000

• Radiation therapy: roughly 2,100 to 5,800 for a course, depending on sessions and technique

• Chemotherapy: about 140 to 2,500 per cycle, with multiple cycles usual

• Diagnostics: around 500 to 1,000 for pre-treatment investigations

• Accommodation: from about 18 to 50 per person per day near the hospital

• Proton beam therapy, where it forms part of the plan: from about 12,000 for a short course up to 49,900 for a full course for patients from SAARC countries, and about 21,500 to 69,900 for other international patients

Two of those lines deserve a second look.

The chemotherapy spread is eighteen-fold, and that is not an error in the sources. The cost is driven almost entirely by which medicines the regimen uses, and that is decided by your tumour biology rather than by choice. A cancer requiring targeted treatment costs considerably more than one that does not.

Accommodation looks small and is not. Over a treatment course measured in months rather than days, it becomes a substantial line rather than an afterthought.

Confirm any figure in writing with the hospital, and ask for the estimate itemised.

13. What an Estimate Should Cover

Ask specifically whether these are inside it:

• Repeat pathology or receptor testing on arrival

• Staging scans, where they have not already been done

• The full course of systemic treatment rather than the first cycles only

• Targeted treatment, where your HER2 result calls for it, which is a significant cost in its own right

• Radiation, where it is part of the plan

• Reconstruction, and whether at the same operation or later

• Hormone treatment for the years afterwards, and whether it can be prescribed at home

• Accommodation across the whole course, and a stay for whoever travels with you

The systemic and hormone treatment lines are the ones patients most often underestimate, because the surgery is a single event and the rest is not.

14. Length of Treatment and Time in the Country

Breast cancer treatment is measured in months rather than weeks, and this is the planning fact that most affects an international patient.

Roughly what each part takes:

• Surgery: a short admission, with a recovery period afterwards

• Chemotherapy: cycles running over several months

• Radiation: daily sessions over a period of weeks

• Hormone treatment: several years, and generally continued at home

Some patients complete everything in India. Others have surgery here and arrange systemic treatment at home, or the reverse. Both are legitimate, and which suits you depends on what is available where you live and on what the team recommends.

Settle this at the planning stage rather than partway through. Ask the team directly which parts of the treatment must happen here, which can be transferred, and what documentation your doctors at home would need to continue.

15. Follow-up

Breast cancer follow-up runs for years. Where hormone treatment is part of the plan, it continues for several years by itself, and monitoring continues alongside it.

Before you leave the country, collect:

• The operation note

• The full histopathology report on the removed tissue, including all receptor results

• All imaging

• A medicine list with doses and durations

• A written follow-up schedule stating which reviews and scans fall due and when

Ask whether the Indian team will review scans and reports sent from home, at what intervals, and how that is arranged. A patient treated abroad without a follow-up plan is the outcome to avoid.

16. Looking Wider

For the treatment pathway across the whole disease, including the non-surgical routes, see the breast cancer treatment pathway.

To compare specialists by discipline, see surgical oncologists in India, medical oncologists and radiation oncologists.

To discuss your own reports, send them to us on WhatsApp at wa.me/919044346292 or by email at care@gaf.healthcare.

Medical Review

Clinical review: required before publication by a breast surgeon, surgical oncologist or medical oncologist.

Medical content review: Dr. Shabnam, BDS, five years in medical content writing and review. Editorial review of medical content, not specialist clinical review.

Editorial review: Abdul Azeem, MA (Public Health specialisation).

Last reviewed: July 2026

Prepared with reference to published oncology guidance and peer-reviewed literature on breast cancer management.

Surgical removal of the tumor via lumpectomy with sentinel lymph node biopsy for early-stage disease, or mastectomy (with optional immediate breast reconstruction) for larger or multifocal tumors.